GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tourmaline Bio Inc (NAS:TRML) » Definitions » Price-to-Tangible-Book

Tourmaline Bio (Tourmaline Bio) Price-to-Tangible-Book : 1.44 (As of May. 12, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Tourmaline Bio Price-to-Tangible-Book?

As of today (2024-05-12), Tourmaline Bio's share price is $14.50. Tourmaline Bio's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $10.08. Hence, Tourmaline Bio's Price to Tangible Book Ratio of today is 1.44.

The historical rank and industry rank for Tourmaline Bio's Price-to-Tangible-Book or its related term are showing as below:

TRML' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.44   Med: 2.6   Max: 2.6
Current: 1.44

During the past 3 years, Tourmaline Bio's highest Price to Tangible Book Ratio was 2.60. The lowest was 1.44. And the median was 2.60.

TRML's Price-to-Tangible-Book is ranked better than
74.45% of 1221 companies
in the Biotechnology industry
Industry Median: 2.7 vs TRML: 1.44

A closely related ratio is called PB Ratio. As of today, Tourmaline Bio's share price is $14.50. Tourmaline Bio's Book Value per Sharefor the quarter that ended in Dec. 2023 was $10.08. Hence, Tourmaline Bio's P/B Ratio of today is 1.44.

Tourmaline Bio Price-to-Tangible-Book Historical Data

The historical data trend for Tourmaline Bio's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tourmaline Bio Price-to-Tangible-Book Chart

Tourmaline Bio Annual Data
Trend Dec21 Dec22 Dec23
Price-to-Tangible-Book
- - 2.60

Tourmaline Bio Quarterly Data
Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Price-to-Tangible-Book Get a 7-Day Free Trial - - - - 2.60

Competitive Comparison of Tourmaline Bio's Price-to-Tangible-Book

For the Biotechnology subindustry, Tourmaline Bio's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tourmaline Bio's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tourmaline Bio's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Tourmaline Bio's Price-to-Tangible-Book falls into.


Tourmaline Bio Price-to-Tangible-Book Calculation

Tourmaline Bio's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2023 )
=14.50/10.082
=1.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price to Tangible Book=Market Cap/Tangible Equity
=Market Cap/(Total Stockholders Equity-Preferred Stock-Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Tourmaline Bio Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Tourmaline Bio's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Tourmaline Bio (Tourmaline Bio) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tourmaline Bio Inc (NAS:TRML) » Definitions » Price-to-Tangible-Book
Comparable Companies
CYTK NUVL KRYS CRSP INSM FOLD BPMC IMGN AXSM ACAD OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
27 West 24th Street, Suite 702, New York, NY, USA, 10010
Website
https://www.tourmalinebio.com
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.